Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Moderna to make its COVID-19 vaccine candidate in Spain

By Chris Newmarker | July 9, 2020

ModernaModerna (NSDQ:MRNA) announced today that Laboratorios Farmacéuticos Rovi has agreed to make Moderna’s COVID-19 vaccine candidate in its Madrid, Spain facility.

The contract for large-scale, commercial fill-finish manufacturing in Spain is but the latest that Moderna has secured as it moves forward with Phase 3 of the clinical trial for its COVID-19 vaccine candidate. Moderna in late June announced a deal to produce the vaccine at a biologics facility that Catalent (NYSE:CTLT) has in Bloomington, Ind.

Rovi as part of its agreement with Moderna will procure a new production line and equipment for compounding, filling, automatic visual inspection and labeling to support the production of hundreds of millions of doses of the vaccine candidate. The goal is to supply markets outside of the U.S. starting in early 2021. ROVI will also hire additional staffing required to support manufacturing operations and production.

“Moderna is committed to helping address the COVID-19 crisis. We are pleased to partner with Rovi to potentially supply hundreds of millions of doses of finished mRNA-1273, once approved, and help address the need for a vaccine against COVID-19 around the world,” Moderna CTO Juan Andres said in a news release. “Rovi’s experience as a global manufacturer of drug product and expertise in fill-finish will be an important partnership for us to establish dedicated supply chains that can meet the needs of different countries and regions. I am delighted to be working with Rovi again.”

Comments

  1. Anthony Laudano says

    August 19, 2020 at 6:34 pm

    Good to hear. moderna seems to be on the ball in the race for an effective vaccine Here’s hoping we have a vaccine by year’s end. That would be great!

    Reply

Tell Us What You Think! Cancel reply

Related Articles Read More >

Pfizer logo
Pfizer seeks to comply with voluntary Net-Zero Standard by 2040
Cambridge Pharma launches with UK plant in Cambridge Research Park
Entegris logo
Entegris opens Life Sciences Technology Center in Massachusetts
sustainability
How pharma can optimize for right-the-first-time drug manufacturing and sustainability

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards